Drug shortages in Canada and their impact on public drug plans, 2017/18 to 2019/20.: H82-54/2022E-PDF
Permanent link to this Catalogue record:
publications.gc.ca/pub?id=9.913490&sl=0
| Department/Agency | Canada. Patented Medicine Prices Review Board, issuing body. |
|---|---|
| Title | Drug shortages in Canada and their impact on public drug plans, 2017/18 to 2019/20. |
| Publication type | Monograph |
| Language | [English] |
| Other language editions | [French] |
| Format | Electronic |
| Electronic document | |
| Note(s) | Issued also in French under title: Les pénuries de médicaments au Canada et leurs répercussions sur les régimes publics d'assurance-médicaments de 2017-2018 à 2019-2020. Issued also in HTML format. Incorrect catalogue number (H28-54/2022E-PDF) printed in this publication. Includes bibliographical references. |
| Publishing information | Ottawa, ON : Patented Medicine Prices Review Board = Conseil d'examen du prix des médicaments brevetés, 2022. ©2022 |
| Description | 1 online resource (45 pages) |
| ISBN | 9780660446226 |
| Catalogue number |
|
| Subject terms | Pharmaceutical services insurance -- Canada. Drug accessibility -- Canada. Drugs -- Supply and demand -- Canada. |
Request alternate formats
To request an alternate format of a publication, complete the Government of Canada Publications email form. Use the form’s “question or comment” field to specify the requested publication.- Date modified: